Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuka Nogami
Decreased Glucagon-Like Peptide 1 Receptor Expression in Endothelial and Smooth Muscle Cells in Diabetic Db/Db Mice: TCF7L2 Is a Possible Regulator of the Vascular Glucagon-Like Peptide 1 Receptor
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Related publications
Equine Glucagon-Like Peptide-1 Receptor Physiology
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)
Science-Business eXchange
Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Synthesis and Biological Evaluation of Glucagon-Like Peptide-1 Receptor Agonists
Archives of Pharmacal Research
Organic Chemistry
Drug Discovery
Molecular Medicine
High Potency Antagonists of the Pancreatic Glucagon-Like Peptide-1 Receptor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Glucagon-Like Peptide-1 and Satiety
Nature
Multidisciplinary
The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice
Physiology and Behavior
Philosophy
Behavioral Neuroscience
Experimental
Cognitive Psychology
